References
- SW Kim, JL Kuti, DP Nicolau. Inhaled antimicrobial therapies for respiratory infections. Curr Infect Dis Rep 2008;10:29–36.
- ZA Kaplancikli, G Turan-Zitouni, A Özdemir, G Revial, K Güven. Synthesis and antimicrobial activity of some thiazolyl-pyrazoline derivatives. Phosphorus, Sulfur, and Silicon 2007;182:749–764.
- DJ Sheehan, CA Hitchcock, CM Sibley. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999;12:40–79.
- G Turan-Zitouni, ZA Kaplancikli, A Özdemir, G Revial, K Güven. Synthesis and antimicrobial activity of some 2-(benzo[d]oxazol/benzo[d]imidazol-2-ylthio)-N-(9H-fluoren-9-yl)acetamide derivatives. Phosphorus, Sulfur, and Silicon 2007;182:639–646.
- S Hood, DW Denning. Treatment of fungal infection in AIDS. J Antimicrob Chemother 1996;37:71–85.
- BD Alexander, JR Perfect. Antifungal resistance trends towards the year 2000: Implications for therapy and new approaches. Drugs 1997;54:657–678.
- MC Raviglione. The TB epidemic from 1992 to 2002. Tuberculosis 2003;83:4–14.
- GJ Churchyard, AD Grant. HIV infection, tuberculosis and nontuberculousmycobacteria. South African Med J 2000;91:472–476.
- CA Benson. Mycobacterium tuberculosis and Mycobacterium avium complex disease in patients with HIV infection. Curr Opin Infect Dis 1994;7:95–107.
- Y Zhang. The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol Toxicol 2005;45:529–564.
- HM Guardiola-Diaz, LA Foster, D Mushrush, ADN Vaz. Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis: Implications for treatment of tuberculosis. Biochem Pharmacol 2001;61:1463–1470.
- KJ McLean, KR Marshall, A Richmond, IS Hunter, K Fowler, T Kieser, SS Gurcha, GS Besra, AW Munro. Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes. Microbiology-SGM 2002;148:2937–2949.
- KJ McLean, MR Cheesman, SL Rivers, A Richmond, D Leys, SK Chapman, GA Reid, NC Price, SM Kelly, J Clarkson, WE Smith, AW Munro. Expression, purification and spectroscopic characterization of the cytochrome P450CYP121 from Mycobacterium tuberculosis. J Inorg Biochem 2002;91:527–541.
- GC Mowat, D Leys, KJ McLean, SL Rivers, A Richmond, AW Munro, MO Lombardia, PM Alzari, GA Reid, SK Chapman, MD Walkinshaw. Crystallization and preliminary crystallographic analysis of a novel cytochrome P450 from Mycobacterium tuberculosis. Acta Cryst 2002;D58:704–705.
- AW Munro, KJ McLean, KR Marshall, AJ Warman, G Lewis, O Roitel, MJ Sutcliffe, CA Kemp, S Modi, NS Scrutton, D Leys. Cytochromes P450: Novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis. Biochem Soc Trans 2003;31:625–630.
- G Menozzi, L Merello, P Fossa, S Schenone, A Ranise, L Mosti, F Bondavalli, R Loddo, C Murgioni, V Mascia, P La Colla, E Tamburini. Synthesis, antimicrobial activity and molecular modeling studies of halogenated 4-[1H-imidazol-1-yl(phenyl)methyl]-1,5-diphenyl-1H-pyrazoles. Bioorg Med Chem 2004;12:5465–5483.
- P Vicini, F Zani, P Cozzini, I Doytchinova. Hydrazones of 1,2-benzisothiazole hydrazides: Synthesis, antimicrobial activity and QSAR investigations. Eur J Med Chem 2002;37:553–564.
- KA Metwally, LM Abdel-Aziz, EM Lashine, MI Husseiny, RH Badawy. Hydrazones of 2-aryl-quinoline-4-carboxylic acid hydrazides: Synthesis and preliminary evaluation as antimicrobial agents. Bioorg Med Chem 2006;14:8675–8682.
- A Gürsoy, N Terzioğlu, G Ötük. Synthesis of some new hydrazide-hydrazones, thiosemicarbazides and thiazolidinones as possible antimicrobials. Eur J Med Chem 1997;32:753–757.
- BN Swamy, TK Suma, GV Rao, GC Reddy. Synthesis of isonicotinoylhydrazones from anacardic acid and their in vitro activity against Mycobacterium smegmatis. Eur J Med Chem 2007;42:420–424.
- D Sriram, P Yogeeswari, RV Devakaram. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides. Bioorg Med Chem 2006;14:3113–3118.
- SG Küçükgüzel, S Rollas. Synthesis, characterization of novel coupling products and 4-arylhydrazono-2-pyrazoline-5-ones as potential antimycobacterial agents. Farmaco 2002;57:583–587.
- PA Bonnet, C Sablayrolles, JP Chapat, B Soulie, MSD Buochberg, G Dusart, M Attisso. Imidazo[1,2-a]pyrazine-2-carboxamidrazones-synthesis and anti-bacterial activity. Eur J Med Chem 1983;18:413–417.
- E Abignente, F Arena, P De Caprariis, R Nuzetti, E Marmo, E Lampa, F Rosatti, R Ottava. Research on heterocyclic-compounds.10. Imidazo[1,2-a]pyrazine derivatives - synthesis and anti-inflammatory activity. Farmaco, Ed Sci 1981;36:61–80.
- MG Rimoli, L Avallone, P de Caprariis, E Luraschi, E Ağabeygnente, W Filippelli, L Berrino, F Rossi. Research on heterocyclic compounds. XXXVII. Synthesis and antiinflammatory activity of methyl-substituted imidazo[1,2-a]pyrazine derivatives. Eur J Med Chem 1997;32:195–203.
- HL Yale, K Losee, J Martins, M Holsing, MF Perry, J Bernstein. Chemotherapy of experimental tuberculosis. VIII. The synthesis of acid hydrazides, their derivatives and related compounds. J Am Chem Soc 1953;75:1933–1942.
- G Turan-Zitouni, ZA Kaplancikli, K Güven. N-(chroman-4-ylidene)aryloxyacetohydrazones: Synthesis and antimicrobial activity. Farmaco 1997;52:631–633.
- NCCLS. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. 2nd ed. Wayne, Pa: NCCLS; 2002., NCCLS document M27-A2 [ISBN 1-56238-469-4].
- L Collins, SG Franzblau. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 1997;41:1004–1009.